Skip to content
Immunomet
MENUMENU
  • About
    • Overview
    • Management
    • Board of Directors
    • Oncology Clinical Advisory Board
    • Scientific Advisory Board
  • Development Programs & Science
    • Overview
    • Lixumistat (IM156) in Oncology
    • Lixumistat (IM156) in Fibrosis
    • Publications
  • Pipeline
  • Investors and Media
    • Featured Articles
  • Contact
Menu Close
MENUMENU
  • About
    • Overview
    • Management
    • Board of Directors
    • Oncology Clinical Advisory Board
    • Scientific Advisory Board
  • Development Programs & Science
    • Overview
    • Lixumistat (IM156) in Oncology
    • Lixumistat (IM156) in Fibrosis
    • Publications
  • Pipeline
  • Investors and Media
    • Featured Articles
  • Contact

Featured Articles

Investors & Media

Featured Articles

February 2018

ImmunoMet featured on JLABS Blog

June 2017
ImmunoMet featured in BioCentury’s Emerging Company Profile

Contact Info

  • Headquarters: JLABS @TMC, 2450 Holcombe Blvd, Houston, TX 77021, USA
  • Email:dwelsch@immunomet.comOpens in your application
Copyright 2018 - ImmunoMet